Skip to main content

Table 3 Administrative and clinical outcomes by fluid cohort

From: Impact of intravenous fluid composition on outcomes in patients with systemic inflammatory response syndrome

Outcome/Complication

Saline

Balanced

Unadjusted odds ratio (95 % confidence interval)

Adjusted odds ratio (95 % confidence interval)

(n = 1558) % (n)

(n = 1558) % (n)

Administrative outcomes

 Cardiac

8.66 (135)

4.43 (69)

0.488 (0.362–0.659)

0.51 (0.378–0.689)

 Hemorrhage

0.71 (11)

0.51 (8)

0.726 (0.291–1.809)

0.781 (0.311–1.961)

 Infectious

10.14 (158)

6.03 (94)

0.569 (0.436–0.742)

0.618 (0.471–0.809)

 Gastrointestinal

5.46 (85)

5.13 (80)

0.938 (0.685–1.284)

0.969 (0.707–1.328)

 Neurologic

1.16 (18)

0.83 (13)

0.72 (0.352–1.474)

0.817 (0.395–1.69)

 Acute renal failure

4.36 (68)

3.34 (52)

0.757 (0.524–1.093)

0.917 (0.625–1.344)

 Respiratory failure

5.46 (85)

3.47 (54)

0.622 (0.439–0.882)

0.692 (0.485–0.986)

 New organ failure

9.11 (142)

7.12 (111)

0.765 (0.59–0.991)

0.872 (0.667–1.141)

Clinical outcomes

 Hospital mortality

3.27 (51)

1.03 (16)

0.307 (0.174–0.54)

0.378 (0.211–0.676)

 30-day readmissions

9.5 (148)

7.64 (119)

0.788 (0.612–1.014)

0.802 (0.622–1.032)

 60-day readmissions

13.54 (211)

10.91 (170)

0.782 (0.63–0.97)

0.798 (0.643–0.991)

 90-day readmissions

16.56 (258)

12.58 (196)

0.725 (0.593–0.886)

0.741 (0.606–0.907)

Cardiac

 Dysrhythmia

10.65 (166)

6.87 (107)

0.618 (0.48–0.797)

0.649 (0.502–0.838)

 Cardiac stress

6.42 (100)

2.05 (32)

0.306 (0.204–0.458)

0.341 (0.226–0.515)

 Heart failure

4.04 (63)

1.48 (23)

0.356 (0.219–0.576)

0.401 (0.246–0.653)

Hemorrhage/Hematologic

 Coagulopathya

11.09 (150)

7.71 (106)

0.67 (0.516–0.87)

0.717 (0.55–0.934)

 Received blood transfusion

2.92 (46)

2.27 (36)

0.777 (0.5–1.209)

0.851 (0.544–1.33)

 Bleeding

20.09 (313)

19.96 (311)

0.992 (0.832–1.182)

1.074 (0.897–1.286)

Infectious

    

 Pneumonia

6.03 (94)

2.12 (33)

0.337 (0.225–0.504)

0.393 (0.259–0.596)

 Sepsis

10.53 (164)

5.65 (88)

0.509 (0.389–0.666)

0.568 (0.431–0.75)

 Urinary tract infection

5.91 (92)

4.69 (73)

0.783 (0.571–1.074)

0.904 (0.653–1.252)

 Line infection

0.77 (12)

0

-

-

Gastrointestinal

 Cholecystitis

4.75 (74)

3.53 (55)

0.734 (0.514–1.048)

0.836 (0.58–1.203)

Renal

 Acute kidney injury

5.46 (85)

4.43 (69)

0.803 (0.580–1.112)

0.920 (0.658–1.286)

Electrolyte abnormalities

 Low magnesium with replacement

4.36 (68)

2.12 (33)

0.474 (0.311–0.723)

0.546 (0.355–0.84)

 High magnesium

4.36 (68)

3.4 (53)

0.772 (0.535–1.113)

0.95 (0.647–1.393)

 Low potassium with replacement

14.12 (220)

7.51 (117)

0.494 (0.39–0.625)

0.551 (0.429–0.706)

 High potassium

9.44 (147)

6.87 (107)

0.708 (0.546–0.918)

0.813 (0.621–1.066)

 Low sodium

39.41 (614)

30.62 (477)

0.678 (0.585–0.787)

0.707 (0.608–0.822)

 High sodium

7 (109)

6.03 (94)

0.854 (0.642–1.135)

1.004 (0.746–1.351)

 Low calcium with replacement

1.28 (20)

0.96 (15)

0.748 (0.381–1.466)

1.052 (0.517–2.14)

Metabolic acidosis

 Lactic (pH and lactate)

0.71 (11)

0.26 (4)

0.362 (0.115–1.139)

0.528 (0.161–1.728)

 Metabolic (pH and bicarbonate)

2.76 (43)

1.22 (19)

0.435 (0.252–0.75)

0.617 (0.342–1.115)

 Hyperchloremic (pH and chloride)

3.47 (54)

1.22 (19)

0.344 (0.203–0.583)

0.449 (0.256–0.786)

  1. aExcluded patients receiving warfarin